| 000 | 01775 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515004408.0 | ||
| 264 | 0 | _c20061107 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0770-3198 | ||
| 024 | 7 |
_a10.1007/s10067-005-0070-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKötter, Ina | |
| 245 | 0 | 0 |
_aCNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cJul 2006 |
||
| 300 |
_a482-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutonomic Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 |
_aBehcet Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aCyclosporine _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEye Diseases _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aGünaydin, Ilhan | |
| 700 | 1 | _aBatra, Marion | |
| 700 | 1 | _aVonthein, Reinhard | |
| 700 | 1 | _aStübiger, Nicole | |
| 700 | 1 | _aFierlbeck, Gerhard | |
| 700 | 1 | _aMelms, Arthur | |
| 773 | 0 |
_tClinical rheumatology _gvol. 25 _gno. 4 _gp. 482-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-005-0070-8 _zAvailable from publisher's website |
| 999 |
_c15887838 _d15887838 |
||